The effects of tamoxifen and soy on dark neuron production in hippocampal formation after pentylenetetrazole-induced repeated seizures in rats

Pathophysiology

Volumn 22, Issue 2, 2015, Pages 125-135

  Ebrahimzadeh Bideskan, Ali Reza ^a   Lale Ataei, Maryam ^b   Mansouri, Somaieh ^c   Hosseini, Mahmoud ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Dark neuron; Hippocampus; Seizure; Soy; Tamoxifen

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; SOYBEAN EXTRACT; TAMOXIFEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DARK NEURON; DENTATE GYRUS; DISEASE SEVERITY; ESTROGEN ACTIVITY; FEMALE; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA2 REGION; HIPPOCAMPAL CA3 REGION; HISTOPATHOLOGY; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE;

EID: 84930045810     PISSN: 09284680     EISSN: 1873149X     Source Type: Journal    
DOI: 10.1016/j.pathophys.2015.04.001     Document Type: Article

References (92)

1. Karimzadeh F., Hosseini M., Mangeng D., Alavi H., Hassanzadeh G.R., Bayat M., et al. Anticonvulsant and neuroprotective effects of Pimpinella anisum in rat brain. BMC Complement Altern. Med. 2012, 12:76. (Epub 2012/06/20).
2. Kohl Z., Uyanik G., Lurding R., Schuierer G., Bogdahn U., Schroder M., et al. Selective bilateral hippocampal lesions after theophylline-induced status epilepticus causes a permanent amnesic syndrome. J. Clin. Neurosci. 2011, 18(7):964-966. (Epub 2011/05/10).
3. Jortner B.S. The return of the dark neuron. A histological artifact complicating contemporary neurotoxicologic evaluation. Neurotoxicology 2006, 27(4):628-634. (Epub 2006/05/03).
4. Fujikawa D.G., Shinmei S.S., Cai B. Seizure-induced neuronal necrosis: implications for programmed cell death mechanisms. Epilepsia 2000, 41(Suppl. 6):S9-S13. (Epub 2000/09/22).
5. Kherani Z.S., Auer R.N. Pharmacologic analysis of the mechanism of dark neuron production in cerebral cortex. Acta Neuropathol. 2008, 116(4):447-452.
6. Ooigawa H., Nawashiro H., Fukui S., Otani N., Osumi A., Toyooka T., et al. The fate of Nissl-stained dark neurons following traumatic brain injury in rats: difference between neocortex and hippocampus regarding survival rate. Acta Neuropathol. 2006, 112(4):471-481.
7. Arai Y., Sekine Y., Murakami S. Estrogen and apoptosis in the developing sexually dimorphic preoptic area in female rats. Neurosci. Res. 1996, 25(4):403-407. (Epub 1996/08/01).
8. Miranda R.C., Sohrabji F., Toran-Allerand D. Interactions of estrogen with the neurotrophins and their receptors during neural development. Horm. Behav. 1994, 28(4):367-375. (Epub 1994/12/01).
9. Stevens S.J., Harden C.L. Hormonal therapy for epilepsy. Curr. Neurol. Neurosci. Rep. 2011, 11(4):435-442.
10. Woolley C.S. Estrogen-mediated structural and functional synaptic plasticity in the female rat hippocampus. Horm. Behav. 1998, 34(2):140-148.
11. Veliskova J. Estrogens and epilepsy: why are we so excited?. Neuroscientist 2007, 13(1):77-88. (Epub 2007/01/19).
12. Nicoletti F., Speciale C., Sortino M.A., Summa G., Caruso G., Patti F., et al. Comparative effects of estradiol benzoate, the antiestrogen clomiphene citrate, and the progestin medroxyprogesterone acetate on kainic acid-induced seizures in male and female rats. Epilepsia 1985, 26(3):252-257. (Epub 1985/05/01).
13. Kokka N., Sapp D.W., Witte U., Olsen R.W. Sex differences in sensitivity to pentylenetetrazol but not in GABAA receptor binding. Pharmacol. Biochem. Behav. 1992, 43(2):441-447. (Epub 1992/10/01).
14. Hosseini M., Sadeghnia H.R., Salehabadi S., Alavi H., Gorji A. The effect of l-arginine and l-NAME on pentylenetetrazole induced seizures in ovariectomized rats, an in vivo study. Seizure 2009, 18(10):695-698. (Epub 2009/10/27).
15. Veliskova J., Velisek L., Galanopoulou A.S., Sperber E.F. Neuroprotective effects of estrogens on hippocampal cells in adult female rats after status epilepticus. Epilepsia 2000, 41(Suppl. 6):S30-S35. (Epub 2000/09/22).
16. Yamano Y., Sakane S., Takamatsu J., Ohsawa N. Estrogen supplementation for bone dematuration in young epileptic man treated with anticonvulsant therapy a case report. Endocr. J. 1999, 46(2):301-307. (Epub 1999/08/25).
17. Hoffman G.E., Moore N., Fiskum G., Murphy A.Z. Ovarian steroid modulation of seizure severity and hippocampal cell death after kainic acid treatment. Exp. Neurol. 2003, 182(1):124-134. (Epub 2003/06/25).
18. Reibel S., Andre V., Chassagnon S., Andre G., Marescaux C., Nehlig A., et al. Neuroprotective effects of chronic estradiol benzoate treatment on hippocampal cell loss induced by status epilepticus in the female rat. Neurosci. Lett. 2000, 281(2-3):79-82. (Epub 2000/03/08).
19. Nelson H.D., Menopause Lancet 2008, 371(9614):760-770. (Epub 2008/03/04).
20. Bayer U., Hausmann M. Sex hormone therapy and functional brain plasticity in postmenopausal women. Neuroscience 2011, 191:118-128.
21. Kotz K., Alexander J.L., Dennerstein L. Estrogen and androgen hormone therapy and well-being in surgically postmenopausal women. J. Women's Health 2006, 15(8):898-908.
22. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer. Lancet 1997, 350(9084):1047-1059. (Epub 1999/04/23).
23. Grady D., Gebretsadik T., Kerlikowske K., Ernster V., Petitti D. Hormone replacement therapy and endometrial cancer risk: a meta-analysis. Obstet. Gynecol. 1995, 85(2):304-313. (Epub 1995/02/01).
24. Hammond C.B. Women's concerns with hormone replacement therapy - compliance issues. Fertil. Steril. 1994, 62(6 Suppl. (2)):157S-160S. (Epub 1994/12/01).
25. Brown N.M., Setchell K.D. Animal models impacted by phytoestrogens in commercial chow: implications for pathways influenced by hormones. Lab. Invest. 2001, 81(5):735-747. (Epub 2001/05/15).
26. Hamilton-Reeves J.M., Vazquez G., Duval S.J., Phipps W.R., Kurzer M.S., Messina M.J. Clinical studies show no effects of soy protein or isoflavones on reproductive hormones in men: results of a meta-analysis. Fertil. Steril. 2010, 94(3):997-1007.
27. Kuiper G.G., Carlsson B., Grandien K., Enmark E., Haggblad J., Nilsson S., et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 1997, 138(3):863-870. (Epub 1997/03/01).
28. +-ATPase reduction in streptozotocin diabetic rats. Diabetes Res. Clin. Pract. 2005, 69(2):107-112.
29. Pan M., Li Z., Yeung V., Xu R.J. Dietary supplementation of soy germ phytoestrogens or estradiol improves spatial memory performance and increases gene expression of BDNF, TrkB receptor and synaptic factors in ovariectomized rats. Nutr. Metab. (Lond.) 2010, 7:75. (Epub 2010/09/17).
30. Liu Y.-Q., Xin T.-R., Lü X.-Y., Ji Q., Jin Y., Yang H.-D. Memory performance of hypercholesterolemic mice in response to treatment with soy isoflavones. Neurosci. Res. 2007, 57(4):544-549.
31. Perez-Martin M., Salazar V., Castillo C., Ariznavarreta C., Azcoitia I., Garcia-Segura L.M., et al. Estradiol and soy extract increase the production of new cells in the dentate gyrus of old rats. Exp. Gerontol. 2005, 40(5):450-453.
32. Schreihofer D.A., Redmond L. Soy phytoestrogens are neuroprotective against stroke-like injury in vitro. Neurosci. 2009, 158(2):602-609.
33. Bu L., Lephart E.D. Soy isoflavones modulate the expression of BAD and neuron-specific beta III tubulin in male rat brain. Neurosci. Lett. 2005, 385(2):153-157.
34. Lovekamp-Swan T., Glendenning M.L., Schreihofer D.A. A high soy diet enhances neurotropin receptor and Bcl-XL gene expression in the brains of ovariectomized female rats. Brain Res. 2007, 1159:54-66.
35. Ebrahimzadeh Bideskan A.R., Hosseini M., Mohammadpour T., Karami R., Khodamoradi M., Nemati Karimooy H., et al. Effects of soy extract on pentylenetetrazol-induced seizures in ovariectomized rats. Zhong Xi Yi Jie He Xue Bao 2011, 9(6):611-618. (Epub 2011/06/15).
36. O'Neill K., Chen S., Diaz Brinton R. Impact of the selective estrogen receptor modulator, tamoxifen, on neuronal outgrowth and survival following toxic insults associated with aging and Alzheimer's disease. Exp. Neurol. 2004, 188(2):268-278.
37. Zheng H., Kangas L., Härkönen P.L. Comparative study of the short-term effects of a novel selective estrogen receptor modulator, ospemifene, and raloxifene and tamoxifen on rat uterus. J. Steroid Biochem. Mol. Biol. 2004, 88(2):143-156.
38. Teunissen S.F., Rosing H., Koornstra R.H.T., Linn S.C., Schellens J.H.M., Schinkel A.H., et al. Development and validation of a quantitative assay for the analysis of tamoxifen with its four main metabolites and the flavonoids daidzein, genistein and glycitein in human serum using liquid chromatography coupled with tandem mass spectrometry. J. Chromatogr. B. 2009, 877(24):2519-2529.
39. Patisaul H.B., Aultman E.A., Bielsky I.F., Young L.J., Wilson M.E. Immediate and residual effects of tamoxifen and ethynylestradiol in the female rat hypothalamus. Brain Res. 2003, 978(1-2):185-193.
40. Michalsen B.T., Gherezghiher T.B., Choi J., Chandrasena R.E., Qin Z., Thatcher G.R., et al. Selective estrogen receptor modulator (SERM) lasofoxifene forms reactive quinones similar to estradiol. Chem. Res. Toxicol. 2012, 25(7):1472-1483. (Epub 2012/05/31).
41. Sharma K., Mehra R.D. Long-term administration of estrogen or tamoxifen to ovariectomized rats affords neuroprotection to hippocampal neurons by modulating the expression of Bcl-2 and Bax. Brain Res. 2008, 1204:1-15.
42. Zhang Y., Jin Y., Behr M.J., Feustel P.J., Morrison J.P., Kimelberg H.K. Behavioral and histological neuroprotection by tamoxifen after reversible focal cerebral ischemia. Exp. Neurol. 2005, 196(1):41-46.
43. Liu J.-L., Tian D.-S., Li Z.-W., Qu W.-S., Zhan Y., Xie M.-J., et al. Tamoxifen alleviates irradiation-induced brain injury by attenuating microglial inflammatory response in vitro and in vivo. Brain Res. 2010, 1316:101-111.
44. Pinilla L., Barreiro M.L., Gonzalez L.C., Tena-Sempere M., Aguilar E. Comparative effects of testosterone propionate, oestradiol benzoate, ICI 182,780, tamoxifen and raloxifene on hypothalamic differentiation in the female rat. J. Endocrinol. 2002, 172(3):441-448. (Epub 2002/03/05).
45. McMillan P.J., LeMaster A.M., Dorsa D.M. Tamoxifen enhances choline acetyltransferase mRNA expression in rat basal forebrain cholinergic neurons. Mol. Brain Res. 2002, 103(1-2):140-145.
46. Kuo J.-R., Wang C.-C., Huang S.-K., Wang S.-J. Tamoxifen depresses glutamate release through inhibition of voltage-dependent Ca2+ entry and protein kinase Cα in rat cerebral cortex nerve terminals. Neurochem. Int. 2012, 60(2):105-114.
47. Borowicz K.K., Luszczki J., Matuszek M., Kleinrok Z., Czuczwar S.J. Effects of tamoxifen, mifepristone and cyproterone on the electroconvulsive threshold and pentetrazole-induced convulsions in mice. Pol. J. Pharmacol. 2002, 54(2):103-109. (Epub 2002/07/26).
48. Patisaul H.B., Luskin J.R., Wilson M.E. A soy supplement and tamoxifen inhibit sexual behavior in female rats. Horm. Behav. 2004, 45(4):270-277.
49. Rakhshandah H., Hosseini M. Potentiation of pentobarbital hypnosis by Rosa damascena in mice. Indian J. Exp. Biol. 2006, 44(11):910-912. (Epub 2007/01/09).
50. Hosseini M., Sharifi M.R., Alaei H., Shafei M.N., Karimooy H.A. Effects of angiotensin II and captopril on rewarding properties of morphine. Indian J. Exp. Biol. 2007, 45(9):770-777. (Epub 2007/10/03).
51. Saffarzadeh F., Eslamizade M.J., Nemati Karimooy H.A., Hadjzadeh M.A., Khazaei M., Hosseini M. The effect of l-arginine on Morris water maze tasks of ovariectomized rats. Acta Physiol. Hung. 2010, 97(2):216-223. (Epub 2010/06/01).
52. Bayat M., Hasanzadeh G.R., BarzroodIpour M., Javadi M. The effect of low protein diet on thalamic projections of hippocampus in rat. Neuroanatomy 2005, 4:43-48.
53. Gost J.I., Insausti R., Gonzalo L.M. Production and characterization of a monoclonal antibody that selectively marks the astrocyte population in the central nervous system. Rev. Med. Univ. Navar. 1993, 38(2):9.
54. Rajabzadeh A.A., Bideskan A.R., Haghir H., Fazel A.R. Morphometrical study of polysialylated neural cell adhesion molecule positive cells in rat pups hippocampus following induction of seizure during pregnancy. Iran. Biomed. J. 2011, 15(4):157-163. (Epub 2012/03/08).
55. Harden C.L., Pulver M.C., Ravdin L., Jacobs A.R. The effect of menopause and perimenopause on the course of epilepsy. Epilepsia 1999, 40(10):1402-1407. (Epub 1999/10/21).
56. Gevorkyan E.S., Nazaryan K.B., Kostanyan A.A. Modifying effect of estradiol and progesterone on epileptic activity of the rat brain. Neurosci. Behav. Physiol. 1989, 19(5):412-415. (Epub 1989/09/01).
57. Pereira M., Soares J.M., Valente S.G., Oliveira P.B., Cavalheiro E.A., Amado D., et al. Estrogen effects on pilocarpine-induced temporal lobe epilepsy in rats. Maturitas 2009, 62(2):190-196.
58. Reddy D.S. Role of hormones and neurosteroids in epileptogenesis. Front. Cell. Neurosci. 2013, 7:115. (Epub 2013/08/06).
59. Kuiper G.G., Lemmen J.G., Carlsson B., Corton J.C., Safe S.H., van der Saag P.T., et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998, 139(10):4252-4263. (Epub 1998/09/29).
60. Kurzer M.S., Xu X. Dietary phytoestrogens. Annu. Rev. Nutr. 1997, 17:353-381. (Epub 1997/01/01).
61. Mackedanz V., Mattos C.B., Feksa L.R., Wannmacher C.M., Wyse A.T. Ovariectomy alters energy metabolism in rat striatum: effect of supplementation with soy diet rich in isoflavones. Metab. Brain Dis. 2011, 26(2):97-105. (Epub 2010/11/13).
62. Makela S., Santti R., Salo L., McLachlan J.A. Phytoestrogens are partial estrogen agonists in the adult male mouse. Environ. Health Perspect. 1995, 103(Suppl. 7):123-127. (Epub 1995/10/01).
63. Chang H.C., Churchwell M.I., Delclos K.B., Newbold R.R., Doerge D.R. Mass spectrometric determination of Genistein tissue distribution in diet-exposed Sprague-Dawley rats. J. Nutr. 2000, 130(8):1963-1970. (Epub 2000/08/05).
64. Lephart E.D., West T.W., Weber K.S., Rhees R.W., Setchell K.D.R., Adlercreutz H., et al. Neurobehavioral effects of dietary soy phytoestrogens. Neurotoxicol. Teratol. 2002, 24(1):5-16.
65. Mohammadpour T., Hosseini M., Karami R., Sadeghnia H.R., Ebrahimzadeh Bideskan A.R., Enayatfard L. Estrogen-dependent effect of soy extract on pentylenetetrazole-induced seizures in rats. Zhong Xi Yi Jie He Xue Bao 2012, 10(12):1470-1476. (Epub 2012/12/22).
66. Lee Y.-B., Lee H.J., Sohn H.S. Soy isoflavones and cognitive function. J. Nutr. Biochem. 2005, 16(11):641-649.
67. Westmark C.J. A hypothesis regarding the molecular mechanism underlying dietary soy-induced effects on seizure propensity. Front. Neurol. 2014, 5:169. (Epub 2014/09/19).
68. Westmark C.J. Soy infant formula and seizures in children with autism: a retrospective study. PLoS ONE 2014, 9(3):e80488. (Epub 2014/03/14).
69. Alkner S., Bendahl P.-O., Fernö M., Nordenskjöld B., Rydén L. Tamoxifen reduces the risk of contralateral breast cancer in premenopausal women: results from a controlled randomised trial. Eur. J. Cancer 2009, 45(14):2496-2502.
70. Kostrzewska A., Laudañski T., Batra S. Potent inhibition by tamoxifen of spontaneous and agonist-induced contractions of the human myometrium and intramyometrial arteries. Am. J. Obstet. Gynecol. 1997, 176(2):381-386.
71. Goulding A., Gold E., Feng W. Tamoxifen in the rat prevents estrogen-deficiency bone loss elicited with the LHRH agonist buserelin. Bone Mineral 1992, 18(2):143-152.
72. Cyr M., Ghribi O., Thibault C., Morissette M., Landry M., Di Paolo T. Ovarian steroids and selective estrogen receptor modulators activity on rat brain NMDA and AMPA receptors. Brain Res. Brain Res. Rev. 2001, 37(1-3):153-161. (Epub 2001/12/18).
73. Cyr M., Morissette M., Landry M., Di Paolo T. Estrogenic activity of tamoxifen and raloxifene on rat brain AMPA receptors. Neuroreport 2001, 12(3):535-539. (Epub 2001/03/10).
74. Carthew P., Edwards R.E., Nolan B.M. Uterotrophic effects of tamoxifen, toremifene, and raloxifene do not predict endometrial cell proliferation in the ovariectomized CD1 mouse. Toxicol. Appl. Pharmacol. 1999, 158(1):24-32.
75. Landry M., Di Paolo T. Effect of chronic estradiol, tamoxifen or raloxifene treatment on serotonin 5-HT1A receptor. Mol. Brain Res. 2003, 112(1-2):82-89.
76. Chen D., Wu C.F., Shi B., Xu Y.M. Tamoxifen and toremifene cause impairment of learning and memory function in mice. Pharmacol. Biochem. Behav. 2002, 71(1-2):269-276.
77. Constantinou A.I., White B.E.P., Tonetti D., Yang Y., Liang W., Li W., et al. The soy isoflavone daidzein improves the capacity of tamoxifen to prevent mammary tumours. Eur. J. Cancer 2005, 41(4):647-654.
78. Ishida K., Shimizu H., Hida H., Urakawa S., Ida K., Nishino H. Argyrophilic dark neurons represent various states of neuronal damage in brain insults: some come to die and others survive. Neuroscience 2004, 125(3):633-644. (Epub 2004/04/22).
79. Sloviter R.S., Dempster D.W. Epileptic" brain damage is replicated qualitatively in the rat hippocampus by central injection of glutamate or aspartate but not by GABA or acetylcholine. Brain Res. Bull. 1985, 15(1):39-60. (Epub 1985/07/01).
80. Pavlova T., Stepanichev M., Gulyaeva N. Pentylenetetrazole kindling induces neuronal cyclin B1 expression in rat hippocampus. Neurosci. Lett. 2006, 392(1-2):154-158. (Epub 2005/10/26).
81. Jafarian M., Rahimi S., Behnam F., Hosseini M., Haghir H., Sadeghzadeh B., et al. The effect of repetitive spreading depression on neuronal damage in juvenile rat brain. Neuroscience 2010, 169(1):388-394. (Epub 2010/05/05).
82. Inta D., Trusel M., Riva M.A., Sprengel R., Gass P. Differential c-Fos induction by different NMDA receptor antagonists with antidepressant efficacy: potential clinical implications. Int. J. Neuropsychopharmacol. 2009, 12(8):1133-1136. (Epub 2009/07/30).
83. Lima-Ojeda J.M., Vogt M.A., Pfeiffer N., Dormann C., Kohr G., Sprengel R., et al. Pharmacological blockade of GluN2B-containing NMDA receptors induces antidepressant-like effects lacking psychotomimetic action and neurotoxicity in the perinatal and adult rodent brain. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2013, 45:28-33. (Epub 2013/05/07).
84. Gass P., Kiessling M., Bading H. Regionally selective stimulation of mitogen activated protein (MAP) kinase tyrosine phosphorylation after generalized seizures in the rat brain. Neurosci. Lett. 1993, 162(1-2):39-42. (Epub 1993/11/12).
85. Herdegen T., Blume A., Buschmann T., Georgakopoulos E., Winter C., Schmid W., et al. Expression of activating transcription factor-2, serum response factor and cAMP/Ca response element binding protein in the adult rat brain following generalized seizures, nerve fibre lesion and ultraviolet irradiation. Neuroscience 1997, 81(1):199-212. (Epub 1997/09/23).
86. Gass P., Prior P., Kiessling M. Correlation between seizure intensity and stress protein expression after limbic epilepsy in the rat brain. Neuroscience 1995, 65(1):27-36. (Epub 1995/03/01).
87. Filipovic D., Zlatkovic J., Inta D., Bjelobaba I., Stojiljkovic M., Gass P. Chronic isolation stress predisposes the frontal cortex but not the hippocampus to the potentially detrimental release of cytochrome c from mitochondria and the activation of caspase-3. J. Neurosci. Res. 2011, 89(9):1461-1470. (Epub 2011/06/10).
88. Filipovic D., Zlatkovic J., Gass P., Inta D. The differential effects of acute vs. chronic stress and their combination on hippocampal parvalbumin and inducible heat shock protein 70 expression. Neuroscience 2013, 236:47-54. (Epub 2013/01/29).
89. Planas A.M., Soriano M.A., Ferrer I., Rodriguez Farre E. Regional expression of inducible heat shock protein-70 mRNA in the rat brain following administration of convulsant drugs. Brain Res. Mol. Brain Res. 1994, 27(1):127-137. (Epub 1994/11/01).
90. Hu R.Q., Koh S., Torgerson T., Cole A.J. Neuronal stress and injury in C57/BL mice after systemic kainic acid administration. Brain Res. 1998, 810(1-2):229-240. (Epub1998/11/14).
91. Zhang H., Xie M., Schools G.P., Feustel P.F., Wang W., Lei T., et al. Tamoxifen mediated estrogen receptor activation protects against early impairment of hippocampal neuron excitability in an oxygen/glucose deprivation brain slice ischemia model. Brain Res. 2009, 1247:196-211.
92. Tanaka M., Sokabe M. Bidirectional modulatory effect of 17beta-estradiol on NMDA receptors via ERalpha and ERbeta in the dentate gyrus of juvenile male rats. Neuropharmacology 2013, 75:262-273. (Epub 2013/08/21).